What is the role of adipokines in myasthenia gravis?

1Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Objective: Myasthenia gravis (MG) is a disease with autoimmune etiology. The main pathomechanism is related to the production of antibodies against nicotinic acetylcholine receptor. The present study is aimed to compare the serum level of adipokines in patients with MG with that in controls, as well as to study the relation of these levels with disease severity. Patients and methods: Fifty patients with MG and 30 healthy individuals were enrolled in our study. Serum concentrations of select adipokines, namely adiponectin, leptin, omentin, visfatin, and resistin were measured. Results: The results showed a significant increase in serum concentrations of adiponectin and resistin in the patients with MG compared with the controls. Conclusion: Further studies are warranted to assess changes in adipokine concentration levels in patients with MG.

Cite

CITATION STYLE

APA

Rozmilowska, I., Czyzewski, D., Mazur, B., & Adamczyk-Sowa, M. (2018). What is the role of adipokines in myasthenia gravis? Therapeutics and Clinical Risk Management, 14, 1515–1525. https://doi.org/10.2147/TCRM.S163966

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free